Scientific, economic, and practical factors should be considered when choosing between the frozen state and lyophilization.

The PharmTech Group interviewed Edwin Stone, CEO of Cellular Origins, about how geopolitical instability in Europe, and ...

FDA chooses Dr. Vinay Prasad, MD, MPH, a hematologist-oncologist, to lead the Center for Biologics Evaluation and Research at FDA.

Amit Chivate, senior market manager, Greater Asia and China, Roquette, provides his perspective on FDA’s recommendations ...

The White House is instructing FDA to increase fees for and inspections of foreign drug manufacturing plants and reduce the ...

The company said the expansion is in response to globally rising demand for inhaled biologics, which offer distinct advantages in route of administration, but can be challenging products for ...

BioPharm International® spoke with Lun Xin, associate director at WuXi Biologics, about high-concentration biologics and some of the biggest challenges associated with their formulation.

The PharmTech Group interviewed Edwin Stone, CEO of Cellular Origins, about how technological advances will impact the biopharma industry in the future.

BioPharm International® sat down with Noah Kopcho, field application scientist at Gyros Protein Technologies, to talk about ...

As therapeutic modalities evolve, so do the challenges and methodologies associated with maintaining and verifying cleanroom ...

Drug developers face increasing pressure to accelerate process development and reduce costs while ensuring safety and efficacy of investigational candidates and marketed products. They must achieve ...

The company is presenting data related to its medications designed to advance the prevention and treatment of asthma and COPD.